Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characterization of ferroptosis signature to evaluate the predict prognosis and immunotherapy in glioblastoma

9 Jul 2021

Abstract excerpt

BACKGROUND: Glioblastoma (GBM) is the most common type of brain cancer with poor survival outcomes and unsatisfactory response to current therapeutic strategies. Recent studies have demonstrated that ferroptosis-related genes (FRGs) are linked with the occurrence and development of GBM and may become promising biological indicators in GBM therapy. METHODS: We systematically assessed the relationship between FRGs...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Ferroptosis and cancer prognosis
Share to Glioma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34244461
DOI: 10.18632/aging.203257

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characterization of ferroptosis signature to evaluate the predict prognosis and immunotherapy in glioblastomaPMID 34244461Read ↗

A Ferroptosis‐Related Prognostic Risk Score Model to Predict Clinical Significance and Immunogenic Characteristics in Glioblastoma MultiformeSemantic proximity Read ↗

New prognostic models in glioblastoma: based ferroptosis-related genes and immune scoresSemantic proximity Read ↗

Identification of Ferroptosis-Related Biomarkers for Prognosis and Immunotherapy in Patients With GliomaSemantic proximity Read ↗

Identification and Validation of an 11-Ferroptosis Related Gene Signature and Its Correlation With Immune Checkpoint Molecules in GliomaSemantic proximity Read ↗

A Novel Ferroptosis-related Gene Signature for Prognosis Prediction in GliomaSemantic proximity Read ↗

Ferroptosis‐related gene signature as a prognostic marker for lower‐grade gliomasSemantic proximity Read ↗

Prognostic Prediction Model for Glioblastoma: A Ferroptosis-Related Gene Prediction Model and Independent External ValidationSemantic proximity Read ↗

Ferroptosis-Related Gene Signature Predicts Glioma Cell Death and Glioma Patient ProgressionSemantic proximity Read ↗

Prognostic Model and Nomogram Construction Based on a Novel Ferroptosis-Related Gene Signature in Lower-Grade GliomaSemantic proximity Read ↗

SLC1A5 Enhances Malignant Phenotypes Through Modulating Ferroptosis Status and Immune Microenvironment in GliomaSemantic proximity Read ↗

Ferroptosis-related NFE2L2 and NOX4 Genes are Potential Risk Prognostic Biomarkers and Correlated with Immunogenic Features in GliomaSemantic proximity Read ↗

Impact of ferroptosis-related risk genes on macrophage M1/M2 polarization and prognosis in glioblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.